Key factors determining the efficacy of gene therapy for continuous DOPA delivery in the Parkinsonian brain

l-DOPA is currently the standard treatment for alleviating the motor symptoms in Parkinson's disease. The therapeutic efficacy, however, diminishes as the disease progresses. It has been suggested that the beneficial effect of l-DOPA could be reestablished by changing the mode of administration...

Full description

Bibliographic Details
Main Authors: Erik Cederfjäll, Gurdal Sahin, Deniz Kirik
Format: Article
Language:English
Published: Elsevier 2012-11-01
Series:Neurobiology of Disease
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0969996111003494

Similar Items